These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 3282415)

  • 41. Beneficial and adverse effects of angiotensin converting enzyme inhibitors.
    Arakawa K
    Adv Exp Med Biol; 1989; 247A():63-71. PubMed ID: 2690592
    [No Abstract]   [Full Text] [Related]  

  • 42. Moderate sodium restriction, angiotensin converting enzyme inhibition, and thiazide diuretic in the management of essential hypertension.
    Singer DR; Markandu ND; Furnival L; Khoshnodi L; MacGregor GA
    J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S5-7. PubMed ID: 2474103
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Emerging benefits of angiotensin converting enzyme inhibitors versus other antihypertensive agents.
    Schoenberger JA
    Am J Med; 1988 Apr; 84(4A):30-5. PubMed ID: 3064606
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An overview of angiotensin-converting enzyme inhibitors in the treatment of hypertension.
    Weber MA
    J Am Osteopath Assoc; 1987 Feb; 87(2 Suppl):175-80. PubMed ID: 3030978
    [No Abstract]   [Full Text] [Related]  

  • 45. The safety of angiotensin-converting enzyme (ACE) inhibitors in moderate hypertension.
    Girard M
    Adverse Drug React Toxicol Rev; 1991; 10(3):169-85. PubMed ID: 1747443
    [No Abstract]   [Full Text] [Related]  

  • 46. [Therapeutic breakthrough often only with combination therapy. An ACE inhibitor plus diuretics in the therapy of hypertension].
    Brunner R
    Fortschr Med Suppl; 1988; 52():3. PubMed ID: 2905334
    [No Abstract]   [Full Text] [Related]  

  • 47. Renoprotective effect of ACE inhibitors: dissecting the molecular clues and expanding the blood pressure goal.
    Remuzzi G
    Am J Kidney Dis; 1999 Nov; 34(5):951-4. PubMed ID: 10561156
    [No Abstract]   [Full Text] [Related]  

  • 48. [Morphological and enzymatic adaptation of skeletal muscle fibers in stroke-prone hypertensive rats to ACE inhibitors].
    Ogoh S; Tsuda K; Taguchi S
    Nihon Seirigaku Zasshi; 1999; 61(7-8):295-304. PubMed ID: 10524265
    [No Abstract]   [Full Text] [Related]  

  • 49. Metabolic and blood pressure effects of angiotensin converting enzyme inhibitors in mild-to-moderate American hypertensives.
    Weinberger MH
    Clin Exp Hypertens A; 1987; 9(2-3):643-52. PubMed ID: 3038428
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Mechanisms of action and clinical use of converting enzyme inhibitors].
    Lazowski J; Rewerski W
    Pol Tyg Lek; 1986 Dec; 41(48):1507-11. PubMed ID: 3035518
    [No Abstract]   [Full Text] [Related]  

  • 51. [Clinical applications of ACE inhibitors].
    Greminger P; Massenkeil G; Eberli F; Siegenthaler W; Vetter W
    Internist (Berl); 1991 Mar; 32(3):139-43. PubMed ID: 1829066
    [No Abstract]   [Full Text] [Related]  

  • 52. Observational series of patients treated either with ACE inhibitors and diuretics or with a homeopathic Crataegus preparation.
    Zanolla L
    Eur J Heart Fail; 2004 Jun; 6(4):509; discussion 517-8; author reply 519. PubMed ID: 15182778
    [No Abstract]   [Full Text] [Related]  

  • 53. The expanding role of angiotensin converting enzyme inhibitors in the management of hypertension.
    Burris JF
    J Clin Pharmacol; 1995 Apr; 35(4):337-42. PubMed ID: 7650220
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Do we need more ACE inhibitors?].
    Haugen O
    Tidsskr Nor Laegeforen; 1990 Apr; 110(11):1411. PubMed ID: 2187274
    [No Abstract]   [Full Text] [Related]  

  • 55. Angiotensin-converting enzyme inhibitors.
    Rotmensch HH; Vlasses PH; Ferguson RK
    Med Clin North Am; 1988 Mar; 72(2):399-425. PubMed ID: 3279286
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Angiotensin converting enzyme inhibitors in the treatment of hypertension: efficacy, metabolic effects and side effects.
    Weinberger MH
    Cardiovasc Drugs Ther; 1987; 1(1):9-13. PubMed ID: 3154313
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The safety of ACE inhibitors for the treatment of hypertension and congestive heart failure.
    Frank GJ
    Cardiology; 1989; 76 Suppl 2():56-67. PubMed ID: 2670222
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Glomerular abnormalities in patients receiving angiotensin converting enzyme inhibitor therapy.
    Lewis EJ
    Kidney Int Suppl; 1987 May; 20():S138-42. PubMed ID: 3037163
    [No Abstract]   [Full Text] [Related]  

  • 59. [Effective combination in the therapy of hypertension. Prof. Dr. H. Brunner, Lausanne, elaborates on the advantages of a combination ACE inhibitor].
    Brunner H
    Fortschr Med Suppl; 1988; 52():10-1. PubMed ID: 2905333
    [No Abstract]   [Full Text] [Related]  

  • 60. ACE inhibitors in hypertension: assessment of taste and smell function in clinical trials.
    Neil-Dwyer G; Marus A
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():169-76. PubMed ID: 2778791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.